GeoVax faces Nasdaq delisting after shares stay below $1 bid price threshold
GOVX•Nasdaq issues delisting determination
GeoVax received a Nasdaq staff determination to delist its common stock for failing the $1 minimum bid price rule.
Shares traded below $1 for 30 consecutive business days from July 16, 2026 through Aug. 26, 2026.
Nasdaq ruled GeoVax ineligible for the usual 180-day cure period due to its 1-for-25 reverse split on Jan. 12, 2026.
Trading is expected to be suspended at the open on Sept. 8, 2026 without a timely hearing request.
A hearing request by Sept. 3, 2026 would stay the delisting process while the appeal is pending.
